Fusion partners of FGFR2 in CCA include ROS, WAC, BICC1, AHCYL1, TACC3, and several others, and these partners are able to trigger auto-dimerization in the absence of FGF and the activation of the downstream tyrosine kinase pathway [35,36]. Here, FGFR2 is linked to cholangiocarcinoma.